105 related articles for article (PubMed ID: 4686402)
1. Determination of dantrolene in biological specimens containing drug-related metabolites.
Hollifield RD; Conklin JD
J Pharm Sci; 1973 Feb; 62(2):271-4. PubMed ID: 4686402
[No Abstract] [Full Text] [Related]
2. Quantitative determination of dantrolene sodium and its metabolites by differential pulse polarography.
Cox PL; Heotis JP; Polin D; Rose GM
J Pharm Sci; 1969 Aug; 58(8):987-9. PubMed ID: 5344536
[No Abstract] [Full Text] [Related]
3. A spectrophotofluorometric procedure for the determination of dantrolene in blood and urine.
Hollifield RD; Conklin JD
Arch Int Pharmacodyn Ther; 1968 Aug; 174(2):333-41. PubMed ID: 5727347
[No Abstract] [Full Text] [Related]
4. Toxicologic and metabolic studies on pentachloronitrobenzene.
Borzelleca JF; Larson PS; Crawford EM; Hennigar GR; Kuchar EJ; Klein HH
Toxicol Appl Pharmacol; 1971 Mar; 18(3):522-34. PubMed ID: 5569827
[No Abstract] [Full Text] [Related]
5. Qualitative method for dantrolene and a related metabolite in urine.
Conklin JD; Sobers RJ
J Pharm Sci; 1973 Jun; 62(6):1024-5. PubMed ID: 4712610
[No Abstract] [Full Text] [Related]
6. Muscle relaxant properties of the identified metabolites of dantrolene.
Ellis KO; Wessels FL
Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):237-40. PubMed ID: 634381
[TBL] [Abstract][Full Text] [Related]
7. Determination of a dantrolene metabolite, 5-(p-nitrophenyl)-2-furoic acid, in plasma and urine by high-performance liquid chromatography.
Wuis EW; Janssen MG; Vree TB; van der Kleijn E
J Chromatogr; 1990 Apr; 526(2):575-80. PubMed ID: 2361999
[No Abstract] [Full Text] [Related]
8. [Studies with C14-labelled N-(4'-chlore-3'-sulfameyl-benzelsulfeny)-N-methyl-2-aminomethyl-2-methyl-tetrahydrefuran. Metabolism and kinetics].
Duhm B; Maul W; Medenwald H; Patzschke K; Wegner LA
Arzneimittelforschung; 1967 Jun; 17(6):672-87. PubMed ID: 5632368
[No Abstract] [Full Text] [Related]
9. Dantrolene sodium: its effect on extrafusal muscle fibers.
Monster AW; Tamai Y; McHenry J
Arch Phys Med Rehabil; 1974 Aug; 55(8):355-62. PubMed ID: 4851262
[No Abstract] [Full Text] [Related]
10. Treatment of spasticity with dantrolene sodium.
Mayer N; Necomber SA; Herman R
Am J Phys Med; 1973 Feb; 52(1):18-29. PubMed ID: 4685519
[No Abstract] [Full Text] [Related]
11. Liquid chromatography in pharmaceutical analysis VII: determination of dantrolene sodium in biological fluids.
Saxena SJ; Honigberg IL; Stewart JT; Vallner JJ
J Pharm Sci; 1977 May; 66(5):751-3. PubMed ID: 874769
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
Ellis KO; Carpenter JF
Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898
[No Abstract] [Full Text] [Related]
13. [Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].
Duhm B; Maul W; Medenwald H; Patzschke K; Wegner LA
Arzneimittelforschung; 1972 Jan; 22(1):42-53. PubMed ID: 5066997
[No Abstract] [Full Text] [Related]
14. Site of action of dantrolene in frog sartorius muscle.
Putney JW; Biancri CP
J Pharmacol Exp Ther; 1974 Apr; 189(1):202-12. PubMed ID: 4545054
[No Abstract] [Full Text] [Related]
15. Synthesis and skeletal muscle relaxant activity of quaternary ammonium salts of dantrolene and clodanolene.
Ellis KO; White RL; Wright GC; Wessels FL
J Pharm Sci; 1980 Mar; 69(3):327-31. PubMed ID: 7381711
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of dantrolene sodium in children.
Lietman PS; Haslam RH; Walcher JR
Arch Phys Med Rehabil; 1974 Aug; 55(8):388-92. PubMed ID: 4853611
[No Abstract] [Full Text] [Related]
17. [Synthesis of some 4-nitrophenylfuran derivates analogs of Dantrolene].
Skwarski D; Sobiak S
Acta Pol Pharm; 1992; 49(5-6):67-9. PubMed ID: 16092204
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography in pharmaceutical analysis VI: determination of dantrolene sodium in a dosage form.
Saxena SJ; Honigberg IL; Stewart JT; Keene GR; Vallner JJ
J Pharm Sci; 1977 Feb; 66(2):286-8. PubMed ID: 839435
[TBL] [Abstract][Full Text] [Related]
19. The use of dantrolene sodium in disorders of the central nervous system.
Chyatte SB; Birdsong JH
South Med J; 1971 Jul; 64(7):830-4. PubMed ID: 4933014
[No Abstract] [Full Text] [Related]
20. Clinical pharmaco--physiology of dantrolene sodium.
Herman R; Mayer N; Mecomber SA
Am J Phys Med; 1972 Dec; 51(6):296-311. PubMed ID: 4564128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
